Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | EVP & Chief Strategy & Corp Op | April 25, 2025 | April 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date April 25, 2025 · Filed April 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,224 |
Ending reported balance
After 2025-04-29 transaction · row 12
12 source rows · reconciled sequenceRow 1 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 2 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 3 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 4 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 5 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 6 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 7 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 8 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 9 · 2025-04-28 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 10 · 2025-04-28 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 11 · 2025-04-29 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 12 · 2025-04-29 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 1,880 |
Reported balance
After 2025-04-29 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-04-29 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $229.39 · Expires 2030-02-27 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 1,880 |
Reported balance
After 2025-04-28 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-04-28 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $304.67 · Expires 2030-08-09 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025.
F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 396 | $368.10 | $145,767.60 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 396 | $245.60 | $97,257.60 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 396 | $375.00 | $148,500.00 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 396 | $347.42 | $137,577.01 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 188 | $368.10 | $69,202.80 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 17:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 188 | $290.33 | $54,582.04 |
DisclosureSEC source: 0001035267-24-000169 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 119 | $0.00 Strike: $304.67 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 37 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 Underlying: Common Stock · 119 shares Expires 2030-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F14 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 120 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 32 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 Underlying: Common Stock · 120 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F13 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 90 | $0.00 Strike: $179.70 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 29 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180 Underlying: Common Stock · 90 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F11 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 120 | $390.16 | $46,819.20 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 26 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 120 | $229.39 | $27,526.80 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 25 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 119 | $390.16 | $46,429.04 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 24 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 119 | $304.67 | $36,255.73 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 23 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 90 | $390.16 | $35,114.40 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 22 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 90 | $179.70 | $16,173.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 21 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,149 | $0.00 Strike: $347.42 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 38 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,382 Underlying: Common Stock · 7,149 shares Expires 2031-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F12 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,437 | $0.00 Strike: $304.67 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 36 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,309 Underlying: Common Stock · 1,437 shares Expires 2030-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F14 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,504 | $0.00 Strike: $290.33 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 35 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,512 Underlying: Common Stock · 1,504 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F10 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 993 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 34 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,382 Underlying: Common Stock · 993 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F10 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 453 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 33 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 453 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F12 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,436 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 31 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,310 Underlying: Common Stock · 1,436 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F13 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 940 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 30 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,511 Underlying: Common Stock · 940 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F12 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 363 | $0.00 Strike: $179.70 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 28 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270 Underlying: Common Stock · 363 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F11 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 453 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · derivative · entry 27 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 453 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F10 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 2,749 | $393.83 | $1,082,641.14 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 20 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,507 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F9 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 515 shares sold at $391.89 to $392.02; 2,034 shares sold at $393.65 to $394.61; and 200 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 2,819 | $393.79 | $1,110,105.85 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 19 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,256 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F8 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 525 shares sold at $391.89 to $392.02; 1,876 shares sold at $393.55 to $394.53; and 418 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 940 | $393.82 | $370,187.42 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 18 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F7 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 940 | $208.90 | $196,366.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 17 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,436 | $393.82 | $565,520.35 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 16 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F7 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,436 | $229.39 | $329,404.04 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 15 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,437 | $393.80 | $565,893.47 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 14 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F6 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 317 shares sold at $391.89 to $392.02; 1,020 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,437 | $304.67 | $437,810.79 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 13 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 453 | $393.80 | $178,390.00 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 12 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 453 | $177.99 | $80,627.98 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 11 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 363 | $393.80 | $142,948.27 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 10 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 363 | $179.70 | $65,231.10 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 9 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 453 | $393.80 | $178,392.58 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 8 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 453 | $242.34 | $109,778.53 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 7 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 993 | $393.80 | $391,045.98 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 993 | $245.60 | $243,880.80 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 7,149 | $393.78 | $2,815,097.48 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.05 as follows: 1,277 shares sold at $391.89 to $392.02; 157 shares sold at $392.50 to $392.52; 4,145 shares sold at $393.53 to $394.53; and 1,570 shares sold at $394.56 to $395.05. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 7,149 | $347.42 | $2,483,681.99 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,504 | $393.81 | $592,287.23 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,075 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 327 shares sold at $391.89 to $392.02; 1,077 shares sold at $393.73 to $394.61; and 100 shares sold at $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:11 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,504 | $290.33 | $436,656.32 |
DisclosureSEC source: 0001035267-24-000122 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 1,504 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,007 Underlying: Common Stock · 1,504 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 2,172 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,172 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 697 | $386.59 | $269,453.23 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,075 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 1,003 | $386.59 | $387,749.77 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,268 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 22:16 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 2,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000083 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.